Concepedia

Karen Melissa Hallow

KM

Statistics

Publications

4

Citations

543

H-Index

4

Active since

2009

Affiliations

University of Georgia(Current)

AstraZeneca (Sweden)

Karen Melissa Hallow is an author at University of Georgia specializing in medicine, renal pharmacotherapy, and inflammation.

Publications per year

2009–2022

4

Publications

4

Why do <scp>SGLT2</scp> inhibitors reduce heart failure hospitalization? <scp>A</scp> differential volume regulation hypothesis

Karen Melissa Hallow, Gabriel Helmlinger, Peter J. Greasley et al. · Diabetes Obesity and Metabolism · 2017 · 482 citations · Full text

Medicine, Cardiology, Pharmacology +17

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet

Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar et al. · Kidney International Reports · 2022 · 29 citations · Full text

Medicine, Endocrinology, Nephrology +17

Markers of inflammation collocate with increased wall stress in human coronary arterial plaque

Karen Melissa Hallow, W. Robert Taylor, Alexander Rachev et al. · Biomechanics and Modeling in Mechanobiology · 2009 · 21 citations

Veterinary Medicine, Cardiology, Pathobiology +14

RAAS Blockade and COVID‐19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro‐Inflammatory and Anti‐Inflammatory Balance

Karen Melissa Hallow, Ishaan Dave · Clinical Pharmacology & Therapeutics · 2021 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–4 of 4